October 5, 2007 — GE Healthcare presented its “Healthcare Re-imagined – Realizing Tomorrow’s Vision, Today” media day earlier this week at GE’s Global Research Center in Niskayuna, NY.
The event featured discussions on new technologies which GE is currently developing.
These technologies reportedly focus on transforming patient care by helping to find disease at its earliest state through diagnostic imaging including cell-based disease detection and treatment and information technology advancements.
Among those topics discussed was the second generation of 4-D Ultrasound that will reportedly produce superior image quality in a device that doctors can hold in the palm of their hand. These ultrasound-tipped catheters may serve as the stethoscopes of the future.
Researchers who helped invent digital x-ray demonstrated GE’s next generation 3D system in a presentation titled “Digital X-Ray and the Future of Cancer” and later discussions focused on how cutting edge technology is being developed with MR and ultrasound to non-invasively treat cancer.
Other spotlights of the event included an inside look at GE’s biosciences lab, where scientists discussed work being done in molecular imaging and diagnostics.
Also at the event, GE announced its collaboration with Eli Lily to co-develop molecular in vitro diagnostics tools for cancer treatments.
The three-year agreement between GE and Lilly will provide GE with access to clinical tissue samples from unidentified patients enrolled in Lilly’s clinical trials.
In turn, Lilly will have access to GE’s advanced technologies in automated tissue-based image analysis and molecular reagents. These tools can be used during drug development to aid Lilly in evaluating the effectiveness of their drug candidates and potentially select patients for future trials.
For more information: www.geheatlhcare.com